BFLY · Butterfly Network, Inc.
$8.72
+0.08 (+0.93%)
At close · Aug 27
Market Cap
$2.30B
Shares
266.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.72
Open$8.70
Day$8.60–9.18
52W close$1.50–9.70
Avg vol 30d6.4M
Short int32.2M · 12.1% float · 4.5d
Short vol49%
Last earningsJul 30, 2026
DataJul 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.39
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+75%
above
Price vs 50-day avg
+8%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
88%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+7%
trailing
6-month return
+139%
trailing
YTD return
+129%
this year
Relative strength
+124%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +45 funds added
Insider flow
Distributing
Net -$40.9M over 90 days · 88% sells
Short interest
Falling
12.08% of float · ▼ -1.6% MoM · 4.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
246 holders — near 3-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
+19%
Y/Y
Gross margin
47%
contracting
EPS growth
+9%
Y/Y
Free cash flow
$-16.0M
Balance sheet
$150.5M
net cash
Quant / Vol
risk profile
Volatility
126%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
Revenue
· Fiscal Year 2026
Raised
$119M – $123M
Apr 30, 2026
$117M – $121M
changed to
Jul 30, 2026
$119M – $123M
prior FY $97.61M
midpoint +24.0% Y/Y
Prior guidance
period ended
· from the 8-K filed Oct 31, 2025
Revenue
· Fiscal Year 2025
$91M – $95M
Guided vs delivered
· last 3 settled
Revenue
Fiscal Year 2025
guided $91M – $95M
$97.61M
Beat +5.0%
Full-year 2023 revenue
full-year 2023
guided at least $64M
$65.9M
In line
Revenue
full year 2022
guided $73M – $76M
$73.39M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+75%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
88%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $8 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +45 funds added
Insider flow
Distributing
Net -$40.9M over 90 days · 88% sells
Short interest
Falling
12.08% of float · ▼ -1.6% MoM · 4.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
246 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $9 · 88%
Range high $10
vs 200-day avg +75%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -7.51M | Six months ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA loss non-GAAP | $1.4M | second quarter of 2026 | — |
| Adjusted EPS non-GAAP | -$0.04 | Six months ended June 30, 2026 | — |
|
|
|||
| Adjusted gross margin non-GAAP | 70.3% | Six months ended June 30, 2026 | — |
|
|
|||
| Adjusted gross profit non-GAAP | 41.57M | Six months ended June 30, 2026 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BFLY
this stock
Butterfly Network, Inc.
|
$2.30B | +129.5% | +19.0% | — | 12.1% |
|
ABT
Abbott Laboratories
|
$198.74B | -10.9% | +5.7% | 32.0 | 1.2% |
|
SYK
Stryker Corp
|
$126.45B | -8.4% | +11.2% | 34.2 | 1.8% |
|
MDT
Medtronic plc
|
$115.17B | -6.3% | +8.4% | 24.1 | 1.1% |
|
BSX
Boston Scientific Corp
|
$68.44B | -51.1% | +12.5% | 19.1 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BFLY | -4.9% | +6.7% | +138.9% | +22.6% | +129.5% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | -6.0% | +2.8% | +124.2% | +19.4% | +116.4% |
Key facts
CIK
1804176
CUSIP
124155102
13F (30d)
206 filings
203 filers
Visit website
Investor relations